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Staphylococcus lugdunensis is a recently described coagulase-
negative staphylococcus (CNS) that has been associated with a
wide range of human infections [1,2].
The most frequent type of infection reported is infective
endocarditis which may involve prosthetic as well as native
valves [3]. In this paper we present a patient with bacterial
arthritis in both knee joints (one with and one without an
arthroplasty), vertebral osteomyelitis and infective endocardi-
tis of nativemitral and aortic valves.
The patient was a 79-year-old male, non-smoking, former
lumberjack with a history of psoriasis and hypertension. He
had seropositive rheumatoid arthritis with general joint a¡ec-
tion. His rheumatoid arthritis was treated with corticoster-
oids, methotrexate and non-steroidal anti-in£ammatory
drugs. He underwent total replacement of the left knee in
November 1992 because of severe osteoarthritis. The right
knee did not show any signs of osteoarthritis until the end of
1994.
He was admitted in April 1995 due to cellulitis of the right
elbow and an infected ulcer on the left foot. Blood cultures
showed growth of CNS, later veri¢ed to be S. lugdunensis.
After initial intravenous treatment with benzylpenicillin and
dicloxacillin for 2 days, the patient was treated with oral clin-
damycin for 2 weeks and the clinical course was uneventful.
On follow-up at the beginning of May, the patient was well
and the C-reactive protein (CRP) serum concentration was
21mg/L.
Nine days later he was readmitted due to bacterial arthritis
of the right knee. Cultures were positive for CNS (later shown
to be S. lugdunensis) in both blood and synovial £uid. This
time, treatment comprised intravenous cloxacillin for 6 days,
then oral £ucloxacillin 1g three times a day for 6weeks, and
then £ucloxacillin 0.5 g three times a day for 7months, in
accordancewith the susceptibility test.
A systolic heart murmur, not previously recognized, led to
a transthoracic echocardiography (TTE) being performed in
August 1995. The TTE showed mild-to-moderate aortic and
mitral valve regurgitation. No vegetations were seen. The
patient was followed with repeated determinations of CRP
and ESRvalues (CRP 10^20mg/L and ESR 20^30mm/1h)
for several months, pending total replacement of the right
knee because of osteonecrosis.This was performed in Novem-
ber 1995. Antibiotic prophylaxis was given as intravenous
cloxacillin 2 g three times a day for 7 days, and the patient was
discharged with oral £ucloxacillin 0.5 g three times a day,
whichwas continued until January1996.
In June 1996 the patient was admitted once more but now
presented symptoms of swelling, pain, e¡usion and warmth
of the left prosthetic knee. Arthrocenthesis was performed and
the patient was given oral £ucloxacillin. The symptoms
recurred over the following year.The CRP levels were 40^80
mg/L and the ESRwas 50^100mm/1h when the symptoms
were present. X-ray investigation of the left knee from this
period showed signs of osteitis. Altogether, six cultures of
synovial £uid were taken from the left knee during this per-
iod, and they all showed growth of CNS, which in February
1997 was typed as S. lugdunensis. Initially, the patient was trea-
ted with oral £ucloxacillin, but repeated susceptibility tests
showed that the isolate had developed resistance to £ucloxacil-
lin in December1996 and the treatment was changed to cipro-
£oxacin (Table1). Later, the isolated strain also showed a
signi¢cantly increasedMIC for cipro£oxacin, and the antibio-
tic treatment was changed to clindamycin.
In June 1997 the patient presented with a history of lower
back pain and arthralgia of the hips, and at this time the CRP
was 175mg/L. The antibiotic regimen was changed to oral
rifampicin plus cipro£oxacin.The patient improved, the CRP
level decreased, and the patient remained well until the end of
August 1997, when he was readmitted due to fever, back and
hip pains. A magnetic resonance imaging (MRI) scan showed
signs of vertebral osteomyelitis, andTTE showed calci¢cation
of the aortic and the mitral valves but no signs of endocarditic
vegetations. Mild-to-moderate mitral and aortic valve regur-
gitation was present, but no signs of cardiac decompensation.
Blood cultures showed growth of S. lugdunensis, and the strain
had now developed resistance to rifampicin. Corticosteroids
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and methotrexate were discontinued and the patient was trea-
ted with intravenous clindamycin. However, the blood cul-
tures were still positive after 1week of intravenous treatment.
A renewedTEE now showed a vegetation on the mitral valve.
Treatment was changed to intravenous vancomycin, and the
patient improved gradually, the fever subsided and the CRP
decreased. Treatment with intravenous vancomycin was con-
tinued for 55 days.
However, at the end of October the patient deteriorated
rapidly and developed shortness of breath due to pneumonia
and heart failure.TTE at this time showed vegetations on both
the aortic and mitral valves and severe mitral and aortic valve
regurgitation. Cipro£oxacin was added to intravenous vanco-
mycin, and had a temporary e¡ect on temperature and CRP
levels. The patient died in acute respiratory and circulatory
failure at the beginning of November1997.
Autopsy showed pneumonia, vertebral osteomyelitis and
infective endocarditis with vegetations of the mitral and aortic
valves, including perforation of bothvalves.
The collection of stored frozen samples at the Department
of Clinical Microbiology was reviewed and 10 isolates were
found (Table1).These strains were thawed and typed to species
level using STAPH-ZYM (Rosco Diagnostica,Taastrup, Den-
mark) and ornithine decarboxylase (ODC) (KEY Scienti¢c
Products, Round Rock,TX, USA). All 10 isolates were typed
as S. lugdunensis biotype 3360^3 ODC. All were positive for
clumping factor (Slidex Staph-Kit, bioMerieux, Marcy
l'Etoile, France) and all were coagulase negative. MICs were
determined using the E-test (AB Biodisk, Solna, Sweden).
Pulsed-¢eld gel electrophoresis (PFGE) (Gene Path system,
Bio-Rad Laboratories, Hercules, CA, USA) was performed,
and all 10 isolates showed an indistinguishable pattern (Figure
1).
Three isolates (from 10 April 1995, 17 December 1996 and
22 August 1997) were tested for the mecA and nuc genes using
PCR [4,5] (Swedish Institute for Infectious Disease Control,
Solna, Sweden), and all these isolates were negative for both
mecA and nuc genes.
S. lugdunensis emerges as an unusually virulent coagulase-
negative staphylococcus causing various types of infections,
ranging from super¢cial skin infections to life-threatening
endocarditis [1,3].
In the present case, the patient had a chronic persistent
infection caused by S. lugdunensis with manifestations from
four di¡erent locations, bacterial arthritis of both knee joints
(with and without prosthesis), vertebral osteomyelitis and
infective endocarditis.
Bacterial arthritis caused by S. lugdunensis has been reported
only once before, and in that case as a complication following
arthroscopy [6].
S. lugdunensis may be considered as part of the resident
£ora of the normal skin and may be found over the entire sur-
face of human skin [1]. The most common types of infection
due to S. lugdunensis have been found to be skin and soft tissue
infections. In addition, during surgical procedures the micro-
organism may be introduced into the wound at the time of
operation, and in this way infectionmay be a result of contam-
ination.
Speci¢c virulence factors similar to those in S. aureus have
not yet been identi¢ed, but toxins such as SLUSH [7,8],
Table 1 Change in antibiotic susceptibility using the E test (MIC values, mg/L) over time for the Staphylococcus lugdunensis strain isolated
from blood and synovial ¯uid
Date
b-




10 April, blood Negative 0.38 0.064 0.19 0.032 0.064 0.004 1.0
13 May, blood Negative 0.38 0.064 0.19 0.032 0.064 0.004 1.0
13 May, synovial ¯uid Negative 0.38 0.094 0.19 0.032 0.064 0.004 1.0








Negative 1.5 0.094 1.5 0.023 0.064 0.003 1.0
6 May, synovial ¯uid Negative 1.5 0.094 4.0 0.047 0.064 0.003 1.0
28 June, synovial ¯uid Negative 1.5 0.094 3.0 0.125 0.094 0.004 1.0
22 August, blood Negative 1.5 0.094 4.0 0.094 0.094 > 32 1.0
7 September, blood Negative 1.5 0.19 6.0 0.094 0.094 > 32 1.0
ãñæConcise Communications
= 2000 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 6, 496±502
enzymes such as proteases, lipases and esterases, and glycoca-
lyx have been reported [9].
The ¢rst case of vertebral osteomyelitis due to S. lugdunensis
was reported in 1996 [10]. In that report, the patient was also
being treated with corticosteroids, due to polymyalgia rheu-
matica, at the onset of symptoms. The patient was, however,
successfully treatedwith isoxazolyl^penicilllin.
A number of case reports and reviews of infective endocar-
ditis due to S. lugdunensis are accumulating in the literature [3].
S. lugdunensis appears to be a potent valvular pathogen causing
endocarditis of both native and prosthetic valves.The portal of
entry is not usually identi¢ed, and a predilection for valvular
abnormalities and immunocompromised patients has been
found [3]. In the present case, the site of entry was probably
the infected knee, and valvular disease might have been pre-
sent since the echocardiography in 1995 revealed mild-to-
moderate regurgitation of both the aortic and the mitral valve.
The patient was also receiving treatment with corticosteroids
andmethotrexate.
A long delay between a probable infection due to S. lugdu-
nensis and the manifestation of endocarditis has been reported
previously [11].
Amost striking ¢nding is the high case-fatality rate despite
adequate antimicrobial treatment. In a report of 11cases with a
mortality rate of 8/11 (73%), none of the fatalities was attribu-
ted to inadequate antibiotic therapy [3]. However, the taking
of consecutive cultures during antibiotic treatment, allowing
evaluation of subsequent development of antibiotic resistance,
has not been reported previously.
Surgery with valve replacement is often required, since the
endocarditis is aggressive and destructive. In addition, patients
who undergo valve replacement appear to have a more favor-
able outcome than those who do not [3,12]. In the present case,
when surgery was considered, the patient was not clinically in
a condition suitable for major surgery and he died as a result of
circulatory and respiratory failure.
Although the patient was treated with antibiotics to which
the isolated strain was, in the initial stages, fully susceptible,
the patient still presented with recurrent episodes of bactere-
mia. Repeated cultures from the synovial £uid of the knee
prosthesis also showed growth of S. lugdunensis despite ade-
quate antibiotic therapy in accordance with in vitro suscept-
ibility tests.
During the various courses of antibiotic treatment, the S.
lugdunensis strain developed a signi¢cant increase in MIC
values at di¡erent times for di¡erent antibiotics; isoxazolyl^
penicillin, cipro£oxacin and rifampicin, respectively. These
changes correlated with the antibiotic regimen given. In addi-
tion, during treatment with clindamycin the patient devel-
oped vertebral osteomyelitis, and during treatment with
cipro£oxacin and rifampicin infective endocarditis was estab-
lished.
Figure 1 Pulsed-®eld gel electrophoresis of 10 S. lugdunensis isolates from a patient with chronic bacterial arthritis, vertebral
osteomyelitis and infective endocarditis over 29 months. (A) Lanes 1 and 13: lambda ladder. Lanes 2, 3, 11 and 12: isolates from
blood. Lanes 4, 5, 6, 8, 9 and 10: isolates from synovial ¯uid. Lane 7: S. aureus ATCC 35556 control strain. (B) Lane 1: same as lane
8 of panel A. Lane 2: S. lugdunensis ATCC 43809 control strain. Lane 3: S. aureus ATCC 35556 control strain.
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Most of the strains of S. lugdunensis previously analyzed
were sensitive to the majority of tested antibiotics, although
resistance has rarely been found to aminoglycosides, macro-
lides and clindamycin. Strains producing b-lactamase have
been reported [2,3,13^15].
In the present case, the 10 isolates from blood and joint
£uid cultures of the patient were indistinguishable when ana-
lyzedwith PFGE.The presence of plasmids has been described
[14], but this aspect was not investigated. The strain did not
possess the mecA gene determined by the PCR method and it
did not produce b-lactamase. The resistance mechanism
against b-lactam antibiotics may be due to speci¢c changes in
the penicillin-binding protein a¤nity or other modi¢cations
of the composition of the cell wall. Resistance to rifampicin
and cipro£oxacin may be due to chromosomal mutations
resulting in changes in RNA polymerase and DNA gyrase or
topoisomerase, respectively.
The present case illustrates the propensity of S. lugdunensis
to cause endocarditis and the di¤culties of controlling the
infection even when antibiotics were given according to the
¢ndings from continual susceptibility testing. Over time, the
infecting strain developed increases inMICvalues for the anti-
microbial agents used for treatment.We hypothesize that the
presence of antimicrobial agents may select for clones with
increased MIC values and ¢nally development of antibiotic
resistance in S. lugdunensis. Based on the present case report,
endocarditis caused by S. lugdunensis must be treated aggres-
sively with antibiotics, and early referral for valve replacement
is mandatory for optimal treatment.
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